InvestorsHub Logo

DewDiligence

11/16/05 11:31 AM

#126 RE: Investorman #125

MRX may be better off without IMDC.

Despite David Pyott’s comments to the contrary, I suspect that what AGN really wants is to quash IMDC’s Reloxin botulinum toxin somehow. Stay tuned.